Coloplast A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPBF research report →
About the company
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- CEO
- Lars Søren Rasmussen
- IPO
- 2000
- Employees
- 16,945
- HQ
- Humlebæk, DK
Price Chart
- Market Cap
- $12.54B
- P/E
- 42.28
- P/S
- 3.17
- P/B
- 6.93
- EV/EBITDA
- 9.88
- Div Yield
- 5.82%
- Gross Margin
- 58.60%
- Op Margin
- 26.47%
- Net Margin
- 7.51%
- ROE
- 14.23%
- ROIC
- 10.58%
- Revenue
- $27.82B · 2.93%
- Net Income
- $3.63B · -28.17%
- EPS
- $16.10 · -28.32%
- Op Income
- $7.57B
- FCF YoY
- 275.28%
- 52W High
- $98.58
- 52W Low
- $56.81
- 50D MA
- $60.80
- 200D MA
- $77.07
- Beta
- 0.53
- Avg Volume
- 1.26K
Get TickerSpark's AI analysis on CLPBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CLPBF coverage
Recent articles, reports, and earnings notes.
No research on CLPBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLPBF report →Similar companies
Peers in the same neighborhood.